$80.06 USD
Updated May 24 12:00am
Add ABBV to WatchlistTrade Grade Buy & Hold Grade Peer Grade Industry Rank
Ranked of 203 in Medical - Pharmaceuticals
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Abbvie develops and markets therapies that address a range of diseases. The Company's products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn's disease, hepatitis C, human immunodeficiency virus, endometriosis, thyroid disease, Parkinson's disease, complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone. The company was founded in 2012 and is based in North Chicago, Illinois.
| Current price | $80.06 |
| Prev. close | $81.15 |
| Day low | $79.87 |
| Day high | $81.10 |
| 50-day MA | $80.09 |
| 200-day MA | $85.90 |
| 52-week high | $103.16 |
| 52-week low | $75.62 |
| Volume | 3,872,900 |
| Avg. volume | 6,277,246 |
| Dividend yield | 5.35% |
| Market Cap | 118.36B |
| 1-mo | 0.91% |
| 3-mo | 1.38% |
| 6-mo | -4.78% |
| 1-year | -17.05% |
| 3-year | 47.06% |
| 5-year | 78.50% |
| YTD | -10.93% |
| 2018 | -0.96% |
| 2017 | 60.07% |
| 2016 | 9.79% |
| 2015 | -6.50% |
| 2014 | 27.92% |
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...